Instead of defibrillator's painful jolt, there may be a gentler way to prevent sudden death

September 28, 2011 in Cardiology

Each year in the United States, more than 200,000 people have a cardiac defibrillator implanted in their chest to deliver a high-voltage shock to prevent sudden cardiac death from a life-threatening arrhythmia. While it's a necessary and effective preventive therapy, those who've experienced a defibrillator shock say it's painful, and some studies suggest that the shock can damage heart muscle.

Scientists at Johns Hopkins believe they have found a kinder and gentler way to halt the rapid and potentially fatal irregular heart beat known as . In a study published in the September 28 issue of Science Translational Medicine, they report success using lower amplitude, high-frequency alternating current at 100-200 Hz to stop the arrhythmia in the laboratory. They say this approach also may prove to be less painful for patients because of the lower amplitude and different frequency range than what is used for standard defibrillator shocks.

"We believe we have found a way to stop a life-threatening arrhythmia by applying a high-frequency alternating current for about one-third of a second," says Ronald Berger, M.D., Ph.D., a cardiac electrophysiologist at the Johns Hopkins Heart and Vascular Institute and a professor of medicine and biomedical engineering at the Johns Hopkins University School of Medicine. "The alternating current puts the disorganized, rapidly moving in a refractory state, like suspended animation. When we turn off the current, the cells immediately return to a normal state. If further research confirms what we have learned so far, this could be less painful for a patient while achieving the same result," says Berger, who is the senior author of the study.

Graduate student Seth Weinberg, a co-lead author of the study, says the way heart cells behave during ventricular fibrillation is like having a football stadium full of fans, all of whom are doing "the wave" in an uncoordinated, disorganized fashion. "Applying the alternating current," he says, "is like freezing all of the fans in a position halfway between sitting and standing. When the current is turned off, the fans sit down in an orderly way, ready to be instructed to do the wave in a coordinated way."

Berger says he and his colleagues, a team of Johns Hopkins cardiologists and biomedical engineers, have shown a proof of principle and a novel scientific finding: It's the first time heart cells have been put in a suspended state to interrupt ventricular fibrillation.

"The idea to put heart cells in a brief state of suspended animation came from studies showing that alternating current could be used to put nerve cells in a similar state to block the signals that cause pain," says Harikrishna Tandri, M.D., assistant professor of medicine and the other co-lead author of the study.

To ensure that they were correctly assessing the response of the heart cells to the high frequency current, and, at the same time, distinguishing the response from the cells' native electrical activity, the researchers used a technique called optical mapping. Unlike other electrical recording techniques, optical mapping measurements are not affected by applied electrical stimuli, according to co-author Leslie Tung, Ph.D., professor of biomedical engineering, who led the optical mapping aspect of the research.

In order to allow the team to explore the response of individual heart cells to the high-frequency electrical current, co-author Natalia Trayanova, Ph.D., professor of biomedical engineering, produced a multi-scale computational model of the heart.

While more testing is needed in animal models, the researchers are optimistic that their work may lead to a new approach to shock the human heart back to a normal rhythm. "We are ultimately hoping to develop a device that, instead of delivering a painful, high-voltage shock when it detects a life-threating arrhythmia, applies a more gentle alternating current for the right amount of time to stop the dangerous rhythm. We think that would be a great benefit to the millions of people worldwide who have a defibrillator to prevent sudden death," Berger says.

Ventricular fibrillation is an uncontrolled twitching or quivering of muscle fibers in the lower chambers of the heart. It is the most dangerous type of and is often caused by a heart attack. During ventricular fibrillation, the heart cannot pump blood to the rest of the body, which leads to sudden death unless the person is revived through CPR or a shock from an external defibrillator. People who are fortunate to have survived ventricular fibrillation and those who have other risk factors, are advised to have an implanted defibrillator to detect ventricular and shock the heart back to a normal rhythm.

Provided by Johns Hopkins Medical Institutions

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • What capacitors to use in a Tesla coil...?
    created15 hours ago
  • Work done by us on the spring
    created17 hours ago
  • Surface current density
    created18 hours ago
  • Work done on body moving in a circle
    created22 hours ago
  • Crest or Trough?
    created22 hours ago
  • Origin of magnetism
    createdMay 25, 2012
  • More from Physics Forums - Classical Physics

More news stories

One-fifth of healthy middle-aged men have low-grade murmur

(HealthDay) -- More than one-fifth of healthy middle-aged men have a low-grade systolic heart murmur that confers a nearly five-fold higher risk of future aortic valve replacement (AVR), according to a study ...

Cardiology created 16 hours ago | popularity not rated yet | comments 0

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.

Cardiology created 17 hours ago | popularity not rated yet | comments 0 | with audio podcast

New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke

An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. The in ...

Cardiology created 22 hours ago | popularity not rated yet | comments 0

Low vitamin D in diet increases stroke risk in Japanese-Americans

Japanese-American men who did not eat foods rich in vitamin D had a higher risk of stroke later in life, according to results of a 34-year study reported in Stroke, an American Heart Association journal.

Cardiology created May 24, 2012 | popularity not rated yet | comments 0

Clot buster seems to help up to 6 hours after stroke

(HealthDay) -- The largest study of its kind finds that stroke patients benefit from a clot-busting drug even six hours after a stroke, suggesting that the current recommended 4.5-hour limit could be expanded.

Cardiology created May 24, 2012 | popularity not rated yet | comments 0


Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Inherited DNA change explains overactive leukemia gene

A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...